Trials / Completed
CompletedNCT05583643
Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment
Syringeable Atorvastatin Loaded Eugenol Enriched PEGylated Cubosomes In-situ Gel for the Intra-pocket Treatment of Periodontitis: Statistical Optimization and Clinical Assessment
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Misr University for Science and Technology · Academic / Other
- Sex
- All
- Age
- 25 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Periodontitis is a destructive chronic inflammatory disease characterized by periodontium damage and pocket formation between the tooth and the gingival margin resulting in ultimate tooth loss. Various topical anti-inflammatory drugs were used to treat inflammation in periodontitis. Introducing atorvastatin as a novel remedy for periodontitis treatment necessitates developing a syringeable modified delivery system capable of targeting inflammation within the periodontal pockets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin Calcium | Atorvastatin loaded into nano particles in-situ gel adjunctive to scaling and debridement |
| DRUG | Atorvastatin Calcium | Atorvastatin loaded into in-situ gel adjunctive to scaling and debridement |
| OTHER | Scaling and debridement only | Scaling and debridement only |
Timeline
- Start date
- 2021-12-07
- Primary completion
- 2022-04-15
- Completion
- 2022-06-30
- First posted
- 2022-10-18
- Last updated
- 2022-10-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05583643. Inclusion in this directory is not an endorsement.